Gendex, headquartered in Des Plaines, IL, with approximately $100 million in annual revenues, is a leading manufacturer of dental imaging products, including intra-oral and panoramic x-ray machines, digital radiography systems, intra-oral cameras, and film processors. First-year Danaher EPS accretion is expected to be $0.02 to $0.03.
"Gendex is a business with an excellent brand name and demographics," commented H. Lawrence Culp, Jr., Danaher's President and Chief Executive Officer. "In addition, the industry is still early in a technology conversion-a shift from film-based to digital imaging-that has been driving above-average growth for the past several years. We see Gendex as an attractive business in its own right, as well as an opportunity to participate in a market with strong long-term fundamentals."
Danaher Corporation is a leading manufacturer of Process/Environmental Controls and Tools and Components. (www.danaher.com)
Statements in this release that are not strictly historical may be "forward-looking" statements, which involve risks and uncertainties. These include risks and uncertainties relating to customer and supplier relationships and prices, competition, market demand, litigation and other contingent liabilities, the integration and operation of acquired businesses, and economic, political, governmental and technological factors affecting the Company's operations, markets, products, services and prices, among others, as set forth in the Company's SEC filings.
SOURCE: Danaher Corporation
CONTACT: Andy Wilson, +1-212-201-2700, ext. 4402 (until 12:00 p.m.),
Web site: http://www.danaher.com/